Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boiron

Showing results (621-630 of 649) with videos related to

Pageof 65
Sort By:
International Journal of Pharmaceutics|December 11, 2012
Pharmaceutical development and optimization of azithromycin suppository for paediatric useTina Kauss, Alexandra Gaubert, Chantal Boyer, et al.
Cancer|August 1, 1973
Evaluation of 216 four-year survivors of acute leukemiaC Jacquillat, M Weil, M F Gemon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITDGaëlle Labouré, Stéphanie Dulucq, Myriam Labopin, et al.
Cancer Research|December 1, 1973
Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris)C Jacquillat, M Weil, M F Gemon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experienceEric Jourdan, Jean-Michel Boiron, Nicole Dastugue, et al.
Experimental Hematology|March 19, 2008
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie CellulaireMauricette Michallet, Quoc-Hung Le, Mohamad Mohty, et al.
Journal of Bacteriology|March 31, 2012
Genome sequence of the human- and animal-pathogenic strain Nocardia cyriacigeorgica GUH-2Anthony Zoropogui, Petar Pujic, Philippe Normand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcomeM Michallet, K Bilger, F Garban, et al.
Leukemia|December 17, 2005
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trialsN Dhédin, H Dombret, X Thomas, et al.
Haematologica|December 5, 2015
STAT1 activation in association with JAK2 exon 12 mutationsAnna L Godfrey, Edwin Chen, Charles E Massie, et al.
Pageof 65

Showing results (621-630 of 649) with videos related to

Sort By:
Pageof 65
International Journal of Pharmaceutics|December 11, 2012
Pharmaceutical development and optimization of azithromycin suppository for paediatric useTina Kauss, Alexandra Gaubert, Chantal Boyer, et al.
Cancer|August 1, 1973
Evaluation of 216 four-year survivors of acute leukemiaC Jacquillat, M Weil, M F Gemon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITDGaëlle Labouré, Stéphanie Dulucq, Myriam Labopin, et al.
Cancer Research|December 1, 1973
Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris)C Jacquillat, M Weil, M F Gemon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experienceEric Jourdan, Jean-Michel Boiron, Nicole Dastugue, et al.
Experimental Hematology|March 19, 2008
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie CellulaireMauricette Michallet, Quoc-Hung Le, Mohamad Mohty, et al.
Journal of Bacteriology|March 31, 2012
Genome sequence of the human- and animal-pathogenic strain Nocardia cyriacigeorgica GUH-2Anthony Zoropogui, Petar Pujic, Philippe Normand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcomeM Michallet, K Bilger, F Garban, et al.
Leukemia|December 17, 2005
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trialsN Dhédin, H Dombret, X Thomas, et al.
Haematologica|December 5, 2015
STAT1 activation in association with JAK2 exon 12 mutationsAnna L Godfrey, Edwin Chen, Charles E Massie, et al.
Pageof 65